Describe a situation where a data quality issue you overlooked caused a delay in a clinical trial report. How did you identify the problem, what steps did you take to correct it, and what changes did you implement to prevent recurrence?
onsite · 3-5 minutes
How to structure your answer
STAR + step‑by‑step strategy (120‑150 words, no story)
Sample answer
I once identified that a missing data flag in our automated validation script had caused 12% of adverse event records to be omitted from a Phase III safety report, delaying the submission by two weeks. I immediately performed a root‑cause analysis, discovering that the flag logic was incorrectly coded for a specific lab test. I corrected the script, re‑ran the pipeline, and validated the output against the source data. I then updated the documentation and added an additional unit test to the CI pipeline. Finally, I presented the findings and the new safeguards to the data governance committee, ensuring transparency. As a result, the corrected report was submitted on schedule, and the updated validation rule reduced similar omissions by 95% in subsequent releases.
Key points to mention
- • Ownership of the error
- • Root cause analysis
- • Corrective action and validation
- • Preventive measures and documentation
- • Stakeholder communication
Common mistakes to avoid
- ✗ Blaming team members instead of taking ownership
- ✗ Failing to quantify the impact of the error
- ✗ Skipping a formal root‑cause analysis